Clinical Trial Update: Oligopin Supplementation and Bone Turnover Markers and Antioxidant Changes in Postmenopausal Osteopenic Women [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Oligopin supplementation and its effects on bone turnover markers and antioxidant changes in postmenopausal women with osteopenia; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia

Drugs mentioned

• Oligopin

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Osteopenia | Phase 3 | Status: COMPLETED